An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease | MicrobiomeTrials← Back to trialsNCT06379646
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-10-24Est. Completion: 2027-04-21
Enrollment target: 6 participants Locations- Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
Background:
Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. Peop…
Bethesda, United StatesEst. completion May 31, 2027
Rheumatic DiseasesLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemArthritisSpondylarthritisAnkylosing SpondylarthritisRheumatoid ArthritisSjogren's Syndrome
Background:
Rheumatic diseases can affect the joints, ligaments, tendons, bones, muscles, and skin. They can also cause…
Bethesda, United StatesEst. completion Jun 15, 2033